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Hounsfield unitAbstract Purpose: The data from routine abdominal multi-detector CT (MDCT) examinations
provide information to diagnosis of the bone mineral density (BMD). The aim of this study was
to measure the effect of intravenous contrast media on the BMD measuring of lumbar spine verte-
brae (L1–L3) with CT densitometric data, Hounsfield unit (HU), obtained by routine abdominal
examinations.
Patients and methods: The data on abdominal CT scans of 261 adults (150 females and 111 males)
with a mean age of 59.6 years who underwent both unenhanced and enhanced abdominal CT exam-
inations, with a 16-slice CT system (Toshiba Alexion Advance Edition 16, Japan), were evaluated
for measuring the bone mineral density.
Results: Using trabecular region of interest (ROI), CT attenuation considerably differed between
the unenhanced and enhanced abdominal scans for each imaging.
Conclusions: BMD values derived from the routine abdominal MDCT can be affected by intra-
venous contrast media in enhanced abdominal CT scanning. The impact of contrast media on
the BMD decreases with increasing age of patients.
 2016 The Egyptian Society of Radiology andNuclearMedicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Osteoporosis is a systemic skeletal disease, which is character-
ized by bone fragility and fracture sensitiveness (1). Patients
with decreased BMD have an increased risk of fracture, the
incidence of which particularly at the hip and spine increases
572 J. Pirayesh Islamian et al.with age in both women and men. Bone mineral density can be
measured in a variety of sites with several techniques.
For BMD assessment of the lumbar vertebrae and proximal
femur, Quantitative computed tomography (QCT) is one of
the standard techniques (2). QCT has grown from its initial
introduction in the 1970s to become an established technique
for evaluating both skeletal condition and response to treat-
ment for osteoporosis and other metabolic bone disease. It is
accepted that QCT is the most sensitive method available to
detect osteoporosis (2–5). While QCT technology delivers a
higher dose than DXA, DXA still represents the ‘‘gold stan-
dard” for diagnosis of osteoporosis and as a technique of
choice. QCT is inimitable between modern noninvasive
measurements of bone mineral as that measures true three-
dimensional BMD as opposed to the area (two-dimensional)
density measures obtained from some protection techniques.
QCT has the ability to measure cortical, trabecular or integral
(cortical plus trabecular) bone at any site of body (6,3).
During the non-contrast abdominal CT examination when
the lumbar vertebrae are in view, the real-time BMD measure-
ment of the lumbar vertebrae by QCT analysis without being
subjected to additional radiation exposure and additional
radiologic examination is defined in the medical literature as
potentially beneficial and superior to Dual-energy X-ray
absorptiometry (DXA) (7,8,5,9).
Because osteoporosis is prevalent and treatable and
conveys a considerable lifetime fracture risk, yet it remains
substantially under diagnosed and undertreated (10–13). Safe
and cost-effective alternatives to increase detection of this
condition are needed.
Abdominal CT is the most frequent radiologic studies,
which are used to assess mass lesions in CT centers. In a
research conducted by Pickhardt et al. (5), it is reported that
the abdominal CT images can be used to Screen patients with
osteoporosis or normal Bone mineral density (5).
Retrieval of BMD data available on body CT examinations
ordered for other indications requires no additional expense,
software package, patient time, medical equipment, orTable 1 The data of HU values in abdominal examinations before an
at L1–L3 vertebrae.
Age Unenhanced
L1 ROI L2 ROI L3 ROI
40–49 190 ± 42 184 ± 41 179 ± 43
50–59 169 ± 40 165 ± 37 158 ± 38
60–69 127 ± 43 121 ± 43 116 ± 42
70–79 100 ± 47 95 ± 46 90 ± 45
Table 2 The data of HU values in abdominal examinations before a
at L1–L3 vertebrae.
Age Unenhanced ROI
L1 ROI L2 ROI L3 ROI
40–49 191 ± 40 184 ± 39 180 ± 40
50–59 169 ± 41 164 ± 39 158 ± 40
60–69 163 ± 43 157 ± 41 150 ± 42
70–79 114 ± 56 110 ± 55 103 ± 49radiation dose, and these data can be retrospectively achieved.
Therefore, it could expand population screening efforts for
osteoporosis.2. Aims and objective
The purpose of our study was to evaluate the influence of
intravenous contrast media on the BMD of lumbar spine
(L1–L3) vertebrae by generating CT densitometric data
(HU) based on routine abdominal with and without contrast
examinations and to investigate whether these data can be
affected on bone density condition.
3. Patients and methods
This retrospective single-institute study, approved by the
institutional review board, was conducted in accordance with
the ethical standards of the Declaration of Helsinki.
All CT studies were accomplished with a 16-slice CT system
(Toshiba Alexion Advance Edition 16, Japan). A routine
MDCT protocol of abdominal examination was used for the
study of all patients. CT parameters were including the follow-
ing: 120 kVp, 160 mA s, 16  1 mm, 0.938 mm respectively for
tube voltage, tube current, beam collimation and pitch factor.
Two dimensional reconstructions (image slice 5 mm, window
width 1500 and window level 300) were obtained in the axial
planes. Elliptical ROI (20 * 10 mm) located in the middle
trabecular portion of each vertebral body before and after
IV contrast injection and the mean CT attenuation were
measured in HU. All ROIs were placed by a radiologist.
Two hundred and sixty-one adults (150 females and 111
males) with a mean age of 59.6 years who underwent both
the unenhanced and enhanced abdominal CT examinations
were evaluated for measuring the bone mineral density. All
patients received VISIPAQUE with an iodine concentration
of 320 mg/ml (iodixanol; GE Healthcare Ireland, Ireland).
The rate of intravenous injection of contrast material was setd after IV contrast administration (portal phase) in females. ROI
Enhanced
L1 ROI L2 ROI L3 ROI
220 ± 45 215 ± 43 209 ± 42
197 ± 43 193 ± 39 185 ± 41
147 ± 49 140 ± 48 136 ± 57
111 ± 50 107 ± 49 103 ± 50
nd after IV contrast administration (portal phase) in males. ROI
Enhanced ROI
L1 ROI L2 ROI L3 ROI
221 ± 41 215 ± 42 210 ± 40
195 ± 43 192 ± 41 185 ± 42
190 ± 45 187 ± 41 179 ± 43
127 ± 57 126 ± 58 119 ± 55
Fig. 1 Computed tomography scans illustrating the calculating vertebral BMD pre- and post-contrast with Hus (a 56 year female).
Corresponding lateral (A) and (B) scout images of the spine. (C) Axial images showing HUvalues (yellow ROI placed in vertebra)
generated in pre-contrast. (D) Axial images showing HU values (yellow ROI placed in vertebra) generated in post-contrast.
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tions. Patients received 1.5 ml of contrast media per kilogram
of body weight. For post-contrast assessment of the BMD of
L1–L3 vertebral body, all measurements were made at the
portal phases.
In Our study we excluded patients with a malignancy and
patients with apparent lumbar spine deformity and history of
damaged trauma in the lumbar spine, because malignancy
and damaged spine could influence on the bone mineral
density (14–16). Also patients less than 40 years of age were
excluded. Patients were grouped by sex and decade of life.4. Statistical analysis
The Statistical analysis was carried out using Statistical
Package for Social Sciences (SPSS) Version 21.0 software for
Windows. Mean HU values and SDs were calculated for
L1–L3 vertebral; Student’s t-tests were used to examine the
significance of the differences. All statistical tests were two-sided.
A p-value of <0.05 was considered statistically significant.
5. Results
Using trabecular ROI, CT attenuation was considerably dif-
fered between the unenhanced and enhanced patients for each
modality imaging. The data of trabecular ROI mean ± SD
HU values, in routine abdominal examinations with and
without contrast media, in the portal phase from the L1 to
L3 vertebrae are shown in Tables 1 and 2.
The HU values were linearly decreased by increasing the
decades of life. Also amplification of mean HU at the
enhanced images in both female and male was decreased with
increasing the age. However, there were no significant differ-
ences for incrementing of HU in the enhanced images between
the sexes, although there was a decrement of mean HU value
in females with an age range of 60–69 years.6. Discussion
Early diagnosis of osteoporosis has a very important impress
in determining the risk of bone fracture. The purpose of this
research was to determine the difference in HU-values of ver-
tebrae from unenhanced and contrast enhanced abdominal
MDCT and to evaluate the impact of contrast media in CT
as a screening tool for identifying patients with osteoporosis
or normal BMD.
In a research conducted by Pickhardt et al. (5), it was
reported that the abdominal CT images can be used to recog-
nize osteoporosis or normal BMD. In another study by
Pickhardt et al., on 252 patients (17), for comparing corpus
vertebrae densities with DXA and QCT, it was found that
when the threshold values were taken at 160 HU in L1 verte-
bra level, at 130 HU at L3 vertebra level and an average of
145 HU between T12-L5 vertebra, the diagnosis of osteoporo-
sis showed a sensitivity of about 100% (see Fig. 1).
The effects of contrast media as an important factor in the
attenuation value of L1 and on the diagnostic value of CT as a
screening tool for osteoporosis were reported by Acu et al.
(18). The image calculated BMD data from 198 patients who
underwent standardized biphasic MDCT, and demonstratedthat IV contrast agent leads to about 8.6% increase in overall
density of L1–L3 from the phase I to phase II (p< 0.0001).
Moreover, comparison of BMD values between phases I and
II reveals a change from osteoporotic to osteopenic condition
in 4.5% of the population and from osteopenic to normal for
11.1% of the subjects. Bauer et al. (19) have shown a higher
attenuation values, 31%, in the spine on contrast-enhanced
CT scans. Also, according to the findings of Toelly el al. (20)
there was a direct relation between the measured BMD values
from unenhanced and arterial phase scans, while the values
from venous phase were consistently higher. We could also
demonstrate that the application of intravenous contrast agent
has a significant influence on the BMD measurement in the
lumbar vertebrae. Our study showed that HU values were
linearly decreased by increasing the decades of life, and thus
confirmed previous study on significant correlation between
age and HU (21). In the current study, CT attenuation (in
HUs) increased considerably in the enhanced CT examina-
tions. For example, at the age group of 40–49, in L1 level, a
mean difference of 30 HU was found between the unenhanced
and the enhanced CT scans; however, in a small-cohort QCT
survey was not detected a noticeable difference (22). In a study
by Pompe et al., (23) BMD was overestimated on the three
examinations as shown by CT-attenuation values (in HUs)
only in the first lumbar vertebra (L1), and also, it was deter-
mined that CT-attenuation values were significantly higher in
contrast-enhanced phases compared to the unenhanced phase.
For individual risk assessment, it is preferable to measure
multiple vertebrae. According to the thresholds defined by
Pickhardt et al., the contrast media in routine abdominal
examinations influence the HU values and so higher ROI
threshold values were needed for diagnosis of osteoporosis.
In the present study, the age groups were classified to
observe the correlation of age with contrast media on the
BMD. A significant correlation was observed between the
age and HUs. The mean HU in females ranged from 30 in
adults to less than 12 in those in their 8th decade. Also the
mean HU in males differs from 34 in full-grown to 14 in those
in their 8th decade.
This study has some limitations which have to be pointed
out. Our study as a retrospective evaluation needed some
larger number of subjects and also included an extended
age ranges to an absolute conclusion. Meanwhile, for an accu-
rate measures, an obvious or known bone abnormalities such
as fractures, deformities, and metastases should not be
included, as well as, regularly calibrating of the imaging system
is necessary to avoid drifting of the CT numbers, proper
selection of vertebrae, and necessity of future prospective
studies, bringing up a need for some more extended studies
to generalize the approach for BMD.
7. Conclusion
Bone mineral density values derived from the routine abdom-
inal multi-detector CT may be affected by intravenous contrast
media in enhanced abdominal CT and the effect decreases with
patient age.
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